New York State Common Retirement Fund Rhythm Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 75,131 shares of RYTM stock, worth $7.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,131
Previous 58,618
28.17%
Holding current value
$7.47 Million
Previous $3.7 Million
104.83%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding RYTM
# of Institutions
282Shares Held
486MCall Options Held
498KPut Options Held
150K-
Perceptive Advisors LLC New York, NY419MShares$41.7 Billion94.44% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$670 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.68MShares$565 Million9.85% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$557 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$497 Million0.01% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.54B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...